1. Barnes CO, Gristick HB, Freund NT, Escolano A, Lyubimov AY, Hartwager H, West AP, Cohen AE, Nussenzweig MC, Bjorklam PJ Structural characterization of a highly potent V3-glycan broably neutralizing antibody bound to natively glycosylated HIV-1 envelope. Nature Communications, March 2018, 9:1251
  2. Medina-Ramirez, Garces F, Escolano A, Skog P, de Taeye S, Moral-Sanchez ID, Dosenovic P, Hua Y, McGuire A, Gitlin A, Woude P, Freund NT, Yasmeen A, Behrens AJ, Ozorowski G, van den Kerkhof T, Sliepen K, Blane T, Kootstra N, van Breemen M, Pritchard L, Stanfield R, Crispin M, Ward A, Stamatatos L, Klasse P, ohn Moore J, Nemazee D, Nussenzweig MC, Wilson I, and Sanders RW Design and crystal structure of a native-like HIV-1envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. J. Exp. Medicine, Aug 2017
    Cited 5 times
  3. Wang H, Gristick HB, Scharf L, West Jr. AP, Galimidi RP, Seaman MS, Freund NT, Nussenzweig MC, Bjorkman PJ Asymmetric recognition of HIV-1 Env trimer by V1V2 loop-targeting antibodies ELIFE, May 2017, e27389.
    Cited 1 time
  4. Freund NT, Haoqing H, Scharf L, Noguiera L, Horwitz JA, Sievers S, Sok D, Golijanin J, Halper-Stromberg A, West A, Lorenzi JC, Toth I, Piechocka-Torcha A, Wang LX, Seaman MS, Burton D, Gazumyan A, Walker BD, Bjorkman PJ, Nussenzweig MC Co-existence of Potent HIV-1 Broadly Neutralizing Antibodies and Antibody-Sensitive Viruses in a Viremic Controller, Science Translational Medicine, Jan 2017 9:373.
    Cited 17 times, highly cited paper
  5. Escolano A, Steichen J, Dosenovic P, Kulp D, Golijanin J, Sok D, Freund NT, Araki T, Lowe S, Chen S, Heinemann J, Oliveira T, Gitlin A, Hui-Yao K, Georgeson E, Karen L, Francisco S, Gazumyan A, Burton D, Schief W.R, Nussenzweig M.C Sequential Immunization Elicits Broadly Neutralizing anti-HIV-1 Antibodies in Ig Knock in Mice. Cell, Sep, 2016, 6:1445.
    Cited 52 times, highly cited paper
  6. Steichen J, Kulp D.W, Tokatlian, T, Escolano A, Docenovic, P, Stanfield RL, McCoy L.E, Ozorowski G, Xiaozhen H, Kalyuzhniy, O, Briney B, Schiffner T, 0arces F, Freund NT, Gitlin, A, Georgeson E, Kubitz M, Adachi Y,  Jones M,  Mutafyan A, Yun D.S, Mayer C, Ward A, Burton D, Wilson IA, Irvine DJ, Nussenzweig MC HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies. Immunity, Sep 2016, 3:483.
    Cited 52 times, highly cited paper.
  7. McGuire AT, Gray MD, Dosenovic P, Gitlin AD,Freund NT, Petersen J, Correnti C, Johnsen W, Kegel R, Stuart AB, Glenn J, Seaman MS, Schief WR, Strong RK, Nussenzweig MC, Stamatatos L Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice. Nature Communications, Feb 2016, 7:10618
    Cited 41 times, highly cited paper
  8. Freund NT, Horwitz JA, Nogueira L, Sievers SA, Scharf L, Scheid JF, Gazumyan A, Liu C, Velinzon K, Goldenthal A, Sanders RW, Moore JP, Bjorkman PJ, Seaman MS, Walker BD, Klein F, Nussenzweig MC A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In Vivo. PloS Pathogens, Oct 2015 11:10.
    Cited 17 times.
  9. Freund NT, Roitburd-Berman A, Sui J, Marasco WA, Gershoni JM Reconstitution of the receptor-binding motif of the SARS coronavirus. PEDS, Dec 2015, 28(12): 567.
    Cited 2 times.
  10. Freund NT, Scheid JF, Mouquet H, Nussenzweig MC Amplification of highly mutated human Ig lambda light chains from an HIV-1 infected patient. Journal of Immunological Methods, Mar 2015, 418:61.
    Cited 1 time
  11. Dosenovic P, von Boehmer L, Escolano A, Jardine J, Freund NT, Gitlin AD, McGuire AT, Kulp DW, Oliveira T, Scharf L, Pietzsch J, Gray MD, Cupo A, van Gils MJ, Yao KH, Liu C, Gazumyan A, Seaman MS, Björkman PJ, Sanders RW, Moore JP, Stamatatos L, Schief WR, Nussenzweig MC Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice. Cell, Sep 2016, 161(7):1505.
    Cited 102 times, highly cited paper
  12. Mayrose I, Penn O, Erez E, Rubinstein ND, Shlomi T, Freund NT, Bublil EM, Ruppin E, Sharan R, Gershoni JM, Martz E, Pupko T   Pepitope: epitope mapping from affinity-selected peptides. Bioinformatics, Dec 2007, 23:3224.
    Cited 80 times
  13. Freund NT, Enshell-Seijffers D, Gershoni JM Phage display selection, analysis, and prediction of B cell epitopes. Current Protocols in Immunology, Aug 2009 Chapter 9:Unit 9.8.
  14. Bublil EM*,Freund NT*, Mayrose I, Penn O, Roitburd-Berman A, Rubinstein ND, Pupko T, Gershoni JM Stepwise prediction of conformational discontinuous B-cell epitopes using the Mapitope algorithm. Proteins: Structure, Function and Bioinformatics 68(1):294.
    Cited 53 times.
  15. Tarnovitski N, Matthews LJ, Sui J, Gershoni JM, Marasco WA. Mapping a neutralizing epitope on the SARS coronavirus spike protein: computational prediction based on affinity-selected peptides. Journal of Molecular Biology, May 2006, 359(1):190.
    Cited 26 times.